Can-Fite BioPharma CANF
NYSE CANF
$2.20 -0.04 (-1.78%)
As of: Oct 2, 2026 · 9:30 AM EDT

Can-Fite BioPharma (CANF) Depreciation & Amortization (CF) (2013)

Updated

Can-Fite BioPharma (CANF) recorded Depreciation & Amortization (CF) of $24,000 in FY2025, up 242.9% from $7,000 in FY2024.

Analysis

Can-Fite BioPharma (CANF) Depreciation & Amortization (CF) (2013) Analysis & Trends

Starting with FY2015, Can-Fite BioPharma's Depreciation & Amortization (CF) history includes 11 years.

  • Annual Depreciation & Amortization (CF) has a five-year compound annual growth rate of 14.9% (FY2020 to FY2025).
  • The FY2025 figure is the highest annual Depreciation & Amortization (CF) in data going back to FY2015.
  • Per Business Quant data, CANF's Depreciation & Amortization (CF) was $7,000 in FY2024 (-53.3%), $15,000 in FY2023 (+7.1%), $14,000 in FY2022 (unchanged) and $14,000 in FY2021 (+16.7%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 Can-Fite BioPharma 1.82 Mn -17.88 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2013 5,000.00
API Access

Can-Fite BioPharma Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=CANF&period=max&api_key=YOUR_API_KEY